Seanergy Dermatology
Organization
Trials
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
Phase 1, Status unknown, 66 people, Nov 4, 2020
Sources: clinicaltrials.gov
Organization
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
Phase 1, Status unknown, 66 people, Nov 4, 2020
Sources: clinicaltrials.gov